Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) for Locally Advanced or Metastatic Pancreatic Adenocarcinoma
(Q56899396)
article by Richard E Royal et al published October 2010 in Journal of Immunotherapy
article by Richard E Royal et al published October 2010 in Journal of Immunotherapy
Language:
Current Data About
Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) for Locally Advanced or Metastatic Pancreatic Adenocarcinoma